Ticker: MBX

Company Overview MBX Biosciences, Inc. (NASDAQ: MBX) is a clinical-stage biopharmaceutical company focused on the development of precision peptide therapies for treating endocrine and metabolic disorders. The firm is advancing several candidates, including its lead product, canvuparatide (MBX 210...